Ligand profile
CHEMBL3827395
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_0569 — ribonucleoside hydrolase 1
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL3827395- UniProt (similar protein)
Q27546- pchembl
- 8.150 (~7.1 nM)
- Target protein
- VK055_0569
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 136.9
- −1 ≤ LogP ≤ 5 -2.09
- MW ≤ 500 Da 265.3
- LogP ≤ 5 -2.09
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 136.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1ncnc2c1N=CC2[C@@H]1N[C@H](CO)[C@@H](O)[C@H]1ONc1ncnc2c1N=CC2[C@@H]1N[C@H](CO)[C@@H](O)[C@H]1O
InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3-5,7,9-10,16-19H,2H2,(H2,12,14,15)/t4?,5-,7+,9-,10+/m1/s1InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3-5,7,9-10,16-19H,2H2,(H2,12,14,15)/t4?,5-,7+,9-,10+/m1/s1
FPUDHSLOMSUPIB-PFLDWWEXSA-NFPUDHSLOMSUPIB-PFLDWWEXSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF01156
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL3827395 →
- UniProt UniProt Q27546 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL3827395”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0569.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).